logo
ProjectCompleted

Fosun Pharma

Sector: Waste Processing and Treatment • Location: China

Source: International Finance Corporation (IFC)

Shanghai Fosun Pharmaceuticals Company Limited (Fosun Pharma or the Company) is a leading Chinese pharmaceutical company focused on research, development, production and distribution of pharmaceutical products in China. The Company currently develops, manufactures and sells over 190 formulations and 20 different types of Active Pharmaceutical Ingredients. Its products have leading market position

Status
Closed
Sector
Waste Processing and Treatment, Manufacturing (Industrial), Water Supply and Storage, Hospital, Government, Education
Location
China
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Fosun Pharma

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Fosun Pharma” is an infrastructure initiative in the Waste Processing and Treatment sector, located in China. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

completed

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Shanghai Fosun Pharmaceuticals Company Limited (Fosun Pharma or the Company) is a leading Chinese pharmaceutical company focused on research, development, production and distribution of pharmaceutical products in China. The Company currently develops, manufactures and sells over 190 formulations and 20 different types of Active Pharmaceutical Ingredients. Its products have leading market positions in the treatment of gynecological and hepatic diseases, diabetes, and malaria. All of the Company’s production facilities are Chinese GMP (Good Manufacturing Practice) compliant. Fosun Pharma also possesses one of the largest wholesale and retail distribution networks for pharmaceutical products in China. The Company holds a 49% stake in Sinopharm Medicine Holding (Sinopharm), one of the largest distributors/retailers in China. China National Pharmaceutical Group (CNPG), a state owned enterprise, owns the remaining 51% in Sinopharm. Together Fosun Pharma and Sinopharm maintain a network of more than 1,500 pharmacies in major cities in China, including Beijing, Shanghai and Shenzhen, and rank as one of top three players in each city.The purpose of the project is to support the operating activities of Fosun Pharma over the next 12-18 months. Fosun Pharma’s total financial requirements in this period are currently estimated at about $100 million.

Original sector

FA - Pharmaceuticals and Medicine

Location

Country

China

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Waste Processing and Treatment, Manufacturing (Industrial), Water Supply and Storage, Hospital, Government, Education

Article published date

2025-08-08

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project